Calculator for ovarian carcinoma subtype prediction
- 1 April 2011
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 24 (4), 512-521
- https://doi.org/10.1038/modpathol.2010.215
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian CancerThe New England Journal of Medicine, 2010
- The biological and clinical value of p53 expression in pelvic high‐grade serous carcinomasThe Journal of Pathology, 2010
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying TheoryThe American Journal of Surgical Pathology, 2010
- Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 TrialJournal of Clinical Oncology, 2009
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker StudiesPLoS Medicine, 2008
- The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?British Journal of Cancer, 2008
- Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinomaBMC Medicine, 2007
- High‐grade ovarian serous carcinoma exhibits significantly higher p16 expression than low‐grade serous carcinoma and serous borderline tumourHistopathology, 2007
- Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific TreatmentJournal of Clinical Oncology, 2004
- Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD InitiativeClinical Chemistry, 2003